Tobramycin Solution
Product Images NDC 65162-914

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 65162-914). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formulation (Tobramycin Inhalation Solution Usp 1)

Chemical structure diagram of Tobramycin showing its molecular configuration with sugar rings and amino groups connected by oxygen atoms.*

FDA Label Image

Pic 7 (Tobramycin Inhalation Solution Usp 10)

An instructional illustration showing a hand placing or removing a booklet labeled 'PlamoAlto' into or from the front compartment of a device, likely representing usage or storage related to the Tobramycin solution inhalation product.*

FDA Label Image

Pic 8 (Tobramycin Inhalation Solution Usp 11)

An instructional line drawing showing a hand unplugging a two-prong electrical plug from a wall outlet, indicated by an arrow pointing away from the outlet. The illustration likely relates to steps in device or equipment use.*

FDA Label Image

Pic 9 (Tobramycin Inhalation Solution Usp 12)

An instructional illustration showing hands holding a Tobramycin Inhalation Solution 300 mg/5 mL ampule. One hand is pulling the bottom tab of the ampule to open it, indicating how to prepare the solution for respiratory inhalation use.*

FDA Label Image

Pic 10 (Tobramycin Inhalation Solution Usp 13)

An instructional diagram showing a hand holding a vial of Tobramycin solution above a respiratory inhalation device, with a drop being released from the vial into the top opening of the device.*

FDA Label Image

Pic 11 (Tobramycin Inhalation Solution Usp 14)

An instructional diagram showing the assembly of a nebulizer device. The image labels parts including the nebulizer top with a semi-circle and stem, the nebulizer cup, and the nebulizer outlet. It illustrates how the nebulizer top fits onto the cup with a twisting motion.*

FDA Label Image

300 mg/5 mL Ampules (Tobramycin Inhalation Solution Usp 15)

An instructional diagram showing assembly of a nebulizer mouthpiece and cup. The mouthpiece is separate and positioned to connect to the nebulizer outlet on the nebulizer cup, which has a handle. Arrows indicate the mouthpiece attaches to the outlet for inhalation use.*

FDA Label Image

Pouch (Tobramycin Inhalation Solution Usp 16)

An instructional illustration showing the assembly of an inspiratory valve cap onto a respiratory inhalation device mouthpiece. Arrows indicate the inspiratory valve cap being placed onto the upper opening of the device.*

FDA Label Image

Carton (Tobramycin Inhalation Solution Usp 17)

Illustration showing a respiratory inhalation device, with labeled parts including an air intake and a detachable mouthpiece or connector at the bottom, designed for delivering Tobramycin inhalation solution.*

FDA Label Image

Tobramycin Inhalation Solution Usp 18

An instructional illustration showing a hand grasping the screen of a Pulmo-Aide nebulizer device, likely demonstrating how to operate or adjust the device for inhalation therapy.*

FDA Label Image

Tobramycin Inhalation Solution Usp 19

An instructional illustration showing a nebulizer device emitting aerosolized mist, representing the use of inhalation solution forms like Tobramycin 300 mg/5 mL respiratory solution. The device includes a mouthpiece and a handle for ease of use during respiratory inhalation therapy.*

FDA Label Image

Figure 1 (Tobramycin Inhalation Solution Usp 2)

A line graph comparing average relative change in FEV1 % predicted over 24 weeks for two studies evaluating Tobramycin Inhalation Solution versus placebo. The graph plots weeks on the x-axis against percentage change on the y-axis, showing treatment periods labeled "on drug" and data for Tobramycin groups and placebo groups in both studies.*

FDA Label Image

Tobramycin Inhalation Solution Usp 20

An instructional line drawing showing a person using a respiratory inhalation device for Tobramycin solution. The person has a nose clip on and is inhaling through the mouthpiece attached to the device.*

FDA Label Image

Tobramycin Inhalation Solution Usp 21

Label images of Tobramycin Inhalation Solution USP 300 mg/5 mL in ampoules. The front side of the ampoules shows the product name and strength, while the back side displays the distributor as Amneal Pharmaceuticals LLC, Bridgewater, NJ, along with an expiration date area. The ampoules are aligned in sets of four.*

FDA Label Image

Tobramycin Inhalation Solution Usp 22

Tobramycin Inhalation Solution, USP 300 mg/5 mL Ampule carton label from Amneal Pharmaceuticals LLC. The label indicates 14 pouches with 4 ampules each, totaling 56 single-use ampules for respiratory inhalation. Storage instructions specify refrigeration. The design includes blue and white color accents and the Amneal logo.*

FDA Label Image

Tobramycin Inhalation Solution Usp 23

Tobramycin Inhalation Solution, USP 300 mg/5 mL ampule packaging label by Amneal Pharmaceuticals LLC. The label indicates the solution is for inhalation only by nebulizer and contains no preservatives. It includes barcode and distributor information, dosage and administration details, and a reserved space for lot and expiration dates.*

FDA Label Image

Figure 2 (Tobramycin Inhalation Solution Usp 3)

A line graph depicting the average change from baseline in log10 colony-forming units (CFUs) over 24 weeks. The graph compares two studies with treatment groups for Tobramycin Inhalation Solution and placebo, showing changes during periods on drug and off drug.*

FDA Label Image

Pic 1 (Tobramycin Inhalation Solution Usp 4)

An instructional diagram labeled with components of a respiratory inhalation setup for Tobramycin solution. It includes an air compressor, nebulizer cup, inspiratory valve cap, ampule, mouthpiece, clean paper or cloth towels, and tubing, showing the arrangement of parts needed for administration.*

FDA Label Image

Pic 2 (Tobramycin Inhalation Solution Usp 5)

An instructional illustration showing two hands holding two single-use ampules labeled 'Tobramycin Inhalation Solution, USP 300 mg/5 mL.' Arrows between the ampules indicate shaking or mixing movement, demonstrating preparation before use.*

FDA Label Image

Pic 3 (Tobramycin Inhalation Solution Usp 6)

An illustration showing a single-dose unit of Tobramycin solution for respiratory inhalation. The image highlights the location of the expiration date on the unit and includes distributor information for Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807.*

FDA Label Image

Pic 4 (Tobramycin Inhalation Solution Usp 7)

An instructional illustration showing the assembly of components for a respiratory inhalation nebulizer. It depicts the positioning of the nebulizer top being inserted into the nebulizer cup, as well as a mouthpiece, tubing, and an inspiratory valve cap arranged nearby.*

FDA Label Image

Pic 5 (Tobramycin Inhalation Solution Usp 8)

Illustration showing the assembly of a nebulizer for inhalation solution. A hand is inserting the nebulizer insert into the nebulizer cup, with an arrow indicating the direction. Labels identify the nebulizer insert, nebulizer cup, and the top orientation of the insert.*

FDA Label Image

Pic 6 (Tobramycin Inhalation Solution Usp 9)

Instructional illustration showing a nebulizer cup and its top component placed on a clean paper or cloth towel. The diagram labels the parts, indicating their correct assembly for use with a respiratory inhalation solution, such as Tobramycin 300 mg/5 mL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.